Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIRAF: Dabigatran vs Warfarin for Cognitive Impairment in AF
NCT01994265Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Nov 2014
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dabigatran in Atrial fibrillation (AFib), sponsored by Universidade de São Paulo. Started Nov 2014; status: completed.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01994265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01994265.